CTNM
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ · Healthcare · Biotechnology · US
$16.70
−4.95%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.03x
- Debt / assets
- 0.03x
- Debt / EBITDA
- -0.10x
- Net debt / EBITDA
- 0.12x
Liquidity & coverage
- Current ratio
- 37.17x
- Quick ratio
- 37.17x
- Cash ratio
- 36.25x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $236.1M
Cash & dividend
- FCF / debt
- -8.13x
- Cash flow / debt
- -8.06x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026